31433496Jabbour EJ, Gökbuget N, Kantarjian HM, Thomas X, Larson RA, Yoon SS, Ghobadi A, Topp MS, Tran Q, Franklin JL, Forman SJ, Stein ASCancerAntibodies, Bispecific; Antineoplastic Agents; Hematopoietic Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation ConditioningAdolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Survival Rate; Young AdultTransplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 study. Cancer. 2019 Dec 01; 125(23):4181-4192.Cancer2019-08-21T00:00:002019Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 study.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000293Living Beings111389680.40057AdolescentD000368Living Beings1341183530.29479AgedD000328Living Beings1578255770.254454AdultD000970Chemicals & Drugs40723510.435494Antineoplastic AgentsD008875Concepts & IdeasLiving Beings1473249570.258834Middle AgedAuthorship 13243240.1816830.1816831authors10.2514has subject areaD005260Physiology1992444050.191184FemaleD006801Living Beings2262862810.130064HumansD008297Physiology1931408600.201635MaleD018380Procedures1408780.592702Hematopoietic Stem Cell TransplantationMedicine-Hematology and OncologyD018033Chemicals & Drugs11210.973874Antibodies, BispecificD019172Procedures623730.824855Transplantation ConditioningD015996Concepts & Ideas45518560.724919Survival RateD054198Disorders723690.73153Precursor Cell Lymphoblastic Leukemia-LymphomaD055815Living Beings97159610.42324Young AdultUniversity of ChicagoRichard A.LarsonRichard A. Larson41.78927490000000-87.601250000000001169Larson, Richard A.Professortrue1ProfessorProfessor